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ABSTRACT: The activity of antimicrobial peptides stems
from their interaction with bacterial membranes, which are
disrupted according to a number of proposed mechanisms.
Here, we investigate the interaction of a model antimicrobial
peptide that contains a single arginine residue with vesicles
containing model lipid membranes. The surfactant-like peptide
Ala6-Arg (A6R) is studied in the form where both termini are
capped (CONH-A6R-NH2, capA6R) or uncapped (NH2-A6R-
OH, A6R). Lipid membranes are selected to correspond to
model anionic membranes (POPE/POPG) resembling those
in bacteria or model zwitterionic membranes (POPC/DOPC)
similar to those found in mammalian cells. Viable antimicrobial
agents should show activity against anionic membranes but not zwitterionic membranes. We ﬁnd, using small-angle X-ray
scattering (SAXS) and cryogenic-TEM (transmission electron microscopy) that, uniquely, capA6R causes structuring of anionic
membranes due to the incorporation of the peptide in the lipid bilayer with peptide β-sheet conformation revealed by circular
dichroism spectroscopy (CD). There is a preferential interaction of the peptide with POPG (which is the only anionic lipid in the
systems studied) due to electrostatic interactions and bidentate hydrogen bonding between arginine guanidinium and lipid
phosphate groups. At a certain composition, this peptide leads to the remarkable tubulation of zwitterionic phosphatidylcholine
(PC) vesicles, which is ascribed to the interaction of the peptide with the outer lipid membrane, which occurs without
penetration into the membrane. In contrast, peptide A6R has a minimal inﬂuence on the anionic lipid membranes (and no β-
sheet peptide structure is observed) but causes thinning (lamellar decorrelation) of zwitterionic membranes. We also investigated
the cytotoxicity (to ﬁbroblasts) and antimicrobial activity of these two peptides against model Gram positive and Gram negative
bacteria. A strong selective antimicrobial activity against Gram positive Listeria monocytogenes, which is an important food-borne
pathogen, is observed for capA6R. Peptide A6R is active against all three studied bacteria. The activity of the peptides against
bacteria and mammalian cells is related to the speciﬁc interactions uncovered through our SAXS, cryo-TEM, and CD
measurements. Our results highlight the exquisite sensitivity to the charge distribution in these designed peptides and its eﬀect on
the interaction with lipid membranes bearing diﬀerent charges, and ultimately on antimicrobial activity.
■ INTRODUCTION
Multilamellar structures are present in biological systems such
as the lipid membranes that comprise the main component of
cell walls. Lipid vesicles are often used as simple models of lipid
membranes in cell walls.
It is known that antimicrobial peptides restructure bacterial
cell membranes, although there are several proposed
mechanisms involving diﬀerent modes of incorporation of
peptides into the lipid membrane (to form pores as in the
barrel-stave model) or adsorption onto the surface of the
membrane (carpet model) with subsequent membrane break-
up or the formation of toroidal pores due to peptide−lipid
curvature.1−4
An important class of antimicrobial peptides are arginine-rich
peptides,4 which undergo strong interactions with lipid
membranes due to electrostatic interactions between the
cationic guanidinium group and anionic or zwitterionic charges
on phosphate groups in lipids.5,6 This can lead to membrane
poration and, hence, antimicrobial activity.
In this work we study the interaction of the peptide Ac-A6R-
NH2 peptide (capA6R; A: alanine, R: arginine) and its
uncapped analogue A6R with lipid membranes. These peptides
belong to the family of surfactant-like peptides (SLPs), which
Received: March 5, 2018
Revised: May 4, 2018
Published: May 8, 2018
Article
pubs.acs.org/BiomacCite This: Biomacromolecules XXXX, XXX, XXX−XXX
© XXXX American Chemical Society A DOI: 10.1021/acs.biomac.8b00391
Biomacromolecules XXXX, XXX, XXX−XXX
consist of a charged headgroup attached to a hydrophobic
sequence.7−11 SLPs have great potential in the development of
antimicrobial agents due to their simple design and short
sequences, along with the potential to display the charged
residue at high density on the surface of self-assembled
nanostructures, which form at suﬃciently high concentration. A
diversity of nanostructures has been reported for this class of
peptide.7−17 In our previous studies, we reported that A6K
forms nanotubes in concentrated aqueous solution.12,13 In
contrast, nanotapes were observed for A6H,
14 and nanosheets
for A6R at low concentration (helical ribbons and nanotubes at
high concentration),15 nanosheets also being observed for
A6D.
16 In another example, the SLP A6RGD, which
incorporates the RGD integrin cell adhesion motif, forms
ﬁbrils or vesicles, depending on the concentration in aqueous
solution.17
Recent work shows that A6K and A9K show antimicrobial
activity against Gram-negative E. coli and Gram-positive S.
aureus,18 and that the antibacterial activity was associated with
self-assembly (or relative amphiphilicity) into elongated,18 since
peptide A3K, which formed irregular aggregates, exhibited
minimal antimicrobial activity against both types of bacteria.
Studying the interaction of antimicrobial peptides (AMPs)
with lipid membranes in bacteria and cells opens a path to
understand the activity of antimicrobial peptides. This knowl-
edge can be applied to improve therapeutics, as part of the
global challenge to overcome emerging antimicrobial resistance
(AMR). Antimicrobial peptides, commonly rich in cationic
residues (in particular arginine or lysine) and hydrophobic
residues,4 are potentially powerful tools to combat AMR
because they act in a nonspeciﬁc way by disrupting bacterial cell
membranes, rather than through any speciﬁc recep-
tor.1,2,3,4,19−24
Here, we investigate the self-assembly of the surfactant-like
peptide Ac-A6R-NH2 (capA6R) and compare it to that of the
uncapped peptide, which was previously reported to form
nanosheet structures in dilute aqueous solution, which wrap
into helical ribbons and nanotubes at higher concentration.15
The uncapped peptide shows promising antimicrobial activity
against Gram positive and Gram negative bacteria.25 Here, the
self-assembly of capA6R is investigated using a combination of
circular dichroism (CD), Fourier transform infrared (FTIR)
spectroscopy, cryogenic-transmission electron microscopy
(cryo-TEM) imaging and small-angle X-ray scattering
(SAXS). A critical aggregation concentration (cac) is located
through ﬂuorescence assays using a probe sensitive to the
formation of β-sheet ﬁbrils.
We then study the binding of capA6R to anionic POPG/
POPE or zwitterionic POPC/DOPC vesicles as model bacterial
and mammalian membranes, respectively.26,27 POPG indicates
2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol) so-
dium salt, POPE denotes 2-oleoyl-1-palmitoyl-sn-glycero-3-
phosphoethanolamine, DOPC denotes 1,2-dioleoyl-sn-glycero-
3-phosphocholine, and POPC denotes 2-oleoyl-1-palmitoyl-sn-
glycero-3-phosphocholine. Studies on model membranes
enable our understanding of the role of individual lipid
components on the function of antimicrobial peptides.28 Our
choice of model anionic and zwitterionic vesicles is based on
the fact that bacterial cell membranes contain signiﬁcant
amounts of phosphatidylethanolamine (PE) and phosphatidyl-
glycerol (PG) lipids.29 On the other hand, mammalian cell
membranes are generally zwitterionic30 and mainly composed
of phosphatidylcholines (PCs).26,31 Also, bacterial cell mem-
branes incorporate peptidoglycan layers, distinct from mamma-
lian cells. This also enables Gram positive and Gram negative
bacteria to be distinguished. Gram positive bacteria have thick
cell walls rich in peptidoglycans and, uniquely, teichoic acids. In
contrast, Gram negative bacteria have a thin membrane with
peptidoglycans located between the cytoplasmic leaﬂet and
Scheme 1. Chemical Structures of the Lipids and Peptides Used in This Work
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lipopolysaccharides incorporated in the outer bacterial
membrane.
Peptide capA6R is capped at the N-terminus with an acetyl
group (CH3CONH2) and is amidated at the C-terminus
(CONH2) so that the only moiety that can bear charge is the
arginine residue. CD is used to study the modiﬁcation of the
peptide conformation in the presence of lipids. Changes in the
lipid membrane due to peptide binding are studied by cryo-
TEM and SAXS. The latter is a particularly powerful method to
determine the ordering of the lamellae within vesicles in situ,
averaged over the sample volume.
We previously studied the self-assembly, cytotoxicity and
antimicrobial activity of A6R in water, and its interaction with
model zwitterionic multilamellar vesicles (MLVs) made of
DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphocholine).15,25
Here we also study the binding of A6R to more realistic
membrane models, that is, anionic POPG/POPE or zwitter-
ionic POPC/DOPC vesicles to understand the inﬂuence of the
capped-termini on capA6R binding to lipids.
We investigate the cytotoxicity and antimicrobial properties
of capA6R using model Gram-positive (S. aureus, L.
monocytogenes) and Gram-negative (E. coli) bacteria. Very
strong and selective antimicrobial activity is observed for L.
monocytogenes for a capA6R concentration where there is a
moderate degree of compatibility to human cells. The
cytotoxicity and antimicrobial properties of capA6R are
compared to those of the uncapped peptide A6R with free
termini. A6R bears two ionizable units, as opposed to capA6R
with only one ionizable unit. Very distinct behavior is observed
comparing the capped and uncapped peptides, with diﬀerent
restructuring of lipid vesicles. This is explained in terms of the
subtle and selective electrostatic interactions with anionic or
zwitterionic lipids.
■ EXPERIMENTAL SECTION
Samples. Peptides A6R and capA6R (Scheme 1) were custom
synthesized by Biomatik (Canada). The peptides were received as
TFA salts, the purities were determined by the supplier to be 96.94
and 95.87%, as determined from HPLC (0.1% TFA in water/
acetonitrile gradient) for A6R and capA6R, respectively. Molar masses
Mw = 600.68 and 641.73 Da were measured by electro-spray ionization
mass spectroscopy (ESI-MS) analysis for A6R and capA6R,
respectively. Lipids 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-rac-(1-
glycerol) sodium salt (POPG; Mw = 770.99 Da), 2-oleoyl-1-palmitoyl-
sn-glycero-3-phosphoethanolamine (POPE; Mw = 718 Da), 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC; Mw = 786.11 Da),
and 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine (POPC; Mw =
760.08 Da; Scheme 1) were purchased from Sigma-Aldrich (U.K.) and
used as received. Peptides capA6R and A6R present a positive charge
+1 in water. Lipids POPE, POPC, and DOPC are zwitterionic in
water, while lipid POPG has a negative charge −1 in water.
Vesicle Preparation. Vesicles were prepared by the thin layer
hydration method, as reported in the literature for hybrid POPE/
POPG vesicles.32 Measured quantities of lipids were dissolved in
chloroform, dried under a stream of nitrogen and placed in a vacuum
chamber for 2 h in order to remove traces of organic solvent. The lipid
ﬁlm was then resuspended in a weighed quantity of water to obtain 0.5
wt % lipid, vortexed at 1800 rpm and 55 °C for 5 min and left to
equilibrate before experiments. Anionic POPG/POPE vesicles were
made to provide a POPG molar fraction ϕPOPG = [POPG]/([POPG]
+ [POPE]) = 0.2 (here [ ] refers to the molar concentration), which
corresponds to a POPG/POPE content 27/73 wt % (e.g., % POPE =
100 × weightPOPE/weight(POPE + POPG)). Zwitterionic vesicles
were made by mixing POPC and DOPC lipids at a ﬁxed molar fraction
of DOPC ϕDOPC = [DOPC]/([POPC] + [DOPC]) = 0.2, which
corresponds to a POPC/DOPC content of 80/20 wt %. The vesicles,
containing ϕPOPG or ϕDOPC, were always prepared with a ﬁxed total 0.5
wt % lipid concentration.
For mixed peptide−lipid samples, a weighed quantity of A6R or
capA6R powder was added to solutions containing the lipid vesicles
described above, to obtain 0.08, 0.25, or 0.5 wt % A6R or capA6R. The
mixtures were then vortexed at 1800 rpm and 55 °C for 5 min and left
to equilibrate before experiments.
Circular Dichroism (CD) Spectroscopy. CD spectra were
recorded using a Chirascan spectropolarimeter (Applied Photophysics,
U.K.). Solutions were placed in a quartz coverslip cuvette (0.01 or 0.1
mm thick). Spectra are presented with absorbance A < 2 at any
measured point with a 0.5 nm step, 1 nm bandwidth, and 1 s collection
time per step. The CD signal from the water background was
subtracted from the CD data of the sample solutions.
Fourier Transform Infrared (FTIR) Spectroscopy. Spectra were
recorded using a Nexus-FTIR spectrometer equipped with a DTGS
detector. Samples were measured using an ATR conﬁguration with a
PEARL liquid cell. Samples were dissolved in D2O. Spectra were
scanned 128 times over the range of 900−4000 cm−1.
X-ray Diﬀraction (XRD). Measurements were performed on stalks
prepared by drying a drop of solution suspended between the ends of
wax-coated capillaries. The stalks were mounted onto a four axis
goniometer of an Oxford Diﬀraction Gemini Ultra instrument. The
sample−detector distance was 44 mm. The X-ray wavelength was λ =
1.54 Å. The wavenumber scale (q = 4π sin θ/λ, where 2θ is the
scattering angle) was geometrically calculated. The detector was a
Sapphire CCD.
Cryogenic-Transmission Electron Microscopy (Cryo-TEM).
Imaging was carried out using a ﬁeld emission cryo-electron
microscope (JEOL JEM-3200FSC), operating at 200 kV. Images
were taken in bright ﬁeld mode and using zero loss energy ﬁltering
(omega type) with a slit width of 20 eV. Micrographs were recorded
using a Gatan Ultrascan 4000 CCD camera. The specimen
temperature was maintained at −187 °C during the imaging. Vitriﬁed
specimens were prepared using an automated FEI Vitrobot device
using Quantifoil 3.5/1 holey carbon copper grids with a hole size of
3.5 μm. Just prior to use, grids were plasma cleaned using a Gatan
Solarus 9500 plasma cleaner and then transferred into the environ-
mental chamber of a FEI Vitrobot at room temperature and 100%
humidity. Thereafter, 3 μL of sample solution was applied on the grid
and it was blotted twice for 5 s and then vitriﬁed in a 1/1 mixture of
liquid ethane and propane at temperature of −180 °C. The grids with
vitriﬁed sample solution were maintained at liquid nitrogen temper-
ature and then cryo-transferred to the microscope.
Small-Angle X-ray Scattering (SAXS). Synchrotron SAXS
experiments on solutions were performed using BioSAXS robots on
beamline BM29 (ESRF, France), on beamline B21 (Diamond Light
Source Ltd., U.K.) or on beamline P1233 (EMBL, Germany). SAXS
experiments on precipitates or gels were performed on beamline I22
(Diamond Light Source Ltd., U.K.). On beamlines B21, BM29, and
P12, solutions were loaded into the 96-well plate of an EMBL
BioSAXS robot and then injected via an automated sample exchanger
into a quartz capillary (1.8 mm internal diameter) in the X-ray beam.
The quartz capillary was enclosed in a vacuum chamber in order to
avoid air scattering. After the sample was injected in the capillary and
reached the X-ray beam, the ﬂow was stopped during the SAXS data
acquisition. B21 operated with a ﬁxed camera length (3.9 m) and ﬁxed
energy (12.4 keV). The images were captured using a Pilatus 2 M
detector. Data processing (background subtraction, radial averaging)
was performed using the dedicated beamline software ScÅtter. BM29
operated with an X-ray wavelength λ = 1.03 Å (12 keV). The images
were captured using a PILATUS 1 M detector, while data processing
was performed using dedicated beamline software ISPYB. Experiments
at P12 were done remotely. The station operated with an X-ray
wavelength λ = 1.24 Å. Data was collected using a PILATUS 1 M
detector and reduced using ATSAS SASFLOW pipeline software.34,35
At I22, precipitates or gels were placed in diﬀerential scanning
calorimetry (DSC) aluminum pans modiﬁed with Teﬂon windows to
enable transmission of the X-ray beam. The sample-to-detector
distance was 7.5 m. A Pilatus P3−2 M detector was used to acquire the
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2D SAXS scattering patterns. SAXS data was corrected for the Teﬂon
background scattering. Diﬀraction from silver behenate was used to
calibrate the wavevector scale of the scattering curve. WAXS data was
collected using a Pilatus detector. Data processing was performed
using software DAWN (Data Analysis Software group, Diamond Light
Source Ltd.).
Fluorescence Assays. Thioﬂavin T (ThT) ﬂuorescence assays
were performed to detect amyloid formation by capA6R, since it is
well-known that ThT ﬂuorescence depends on the formation of
amyloid-like structures (β-sheet ﬁbrils).36,37 For the ThT assay,
emission spectra were recorded from 460 to 600 nm using an
excitation wavelength λex = 440 nm for peptide solutions containing
5.0 × 10−3 wt % ThT.
Cytotoxicity Assays. The cytotoxicity of A6R and capA6R was
examined. In vitro cell culture was conducted using the 161br
(ECACC) human skin ﬁbroblast cell line. Cells were cultured in
EMEM (Eagle’s Minimum Essential Medium), with 2 mM glutamine,
enriched with 15% fetal bovine serum (FBS), 1% nonessential amino
acids (NEAA), and 1% antibiotic-antimycotic (Thermoscientiﬁc,
100×). Cells were maintained in a humidiﬁed atmosphere of 5%
CO2 at 37 °C.
Cell viability eﬀects were examined using the MTT 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. A6R
and capA6R were dissolved in complete medium. Cells were seeded
into a 96-well plate at a seeding density of 4 × 104 cells/mL, and
allowed to adhere for 24 h in 100 μL complete medium. After 24 h, a
total volume of 100 μL of either complete medium and/or peptide
solution was added, to give ﬁnal peptide concentrations of 0.5, 0.25,
0.1, 0.05, 0.01, or 0.005 wt % peptide. Negative controls of peptide in
complete medium with no cells were included.
After 67 h of incubation, 20 μL of MTT (0.5 wt % in PBS) was
added to each well plate and allowed to incubate for 5 h (total of 72 h
incubation). After this, the solutions were removed from the wells and
replaced with 100 μL DMSO per well in order to dissolve the
formazan crystals. Plates were incubated for 30 min, and then analyzed
using a UV microplate reader (λ = 570 nm). Results are reported
[(treated cells − negative control)/(untreated cells)] × 100.38−40 The
ANOVA and Bonferoni post hoc test were used to determine whether
there was statistical signiﬁcance.
Bacterial Strains and Growth Condition. Experiments were
performed with three diﬀerent microorganisms, namely, Staphylococcus
aureus, Listeria monocytogenes, and Escherichia coli. The strains used
were a wild-type strain of S. aureus previously isolated from ham,41 a
widely used wild-type strain of L. monocytogenes (LO2842,43), and one
of the most widely used E. coli strains (K-12). Stock cultures were
stored at −80 °C in 7% (v/v) DMSO (Sigma-Aldrich, Dorset, U.K.).
Prior to experiments, stock cultures of S. aureus and L. monocytogenes
were streaked onto brain heart infusion (BHI) agar (LAB M,
Lancashire, U.K.), while those of E. coli were streaked onto Lysogeny
Broth (LB) agar (Oxoid, U.K.) and incubated overnight at 37 °C
Preparation of Cell Suspensions. Three colonies from these
cultures were then transferred to 3 mL of sterile Tryptone soy broth
(TSB) supplemented with 0.3% (w/v) yeast extract (TSBY; Oxoid,
U.K.) and grown at 37 °C under agitation at 150 rev min−1 on a
Gallenkamp orbital shaker for 24 h. Subsequently, 20 mL of selected
broth TSB broth was inoculated with the previously prepared
overnight cultures up to 1% and grown at 37 °C under an agitation
of 150 rev min−1 for a further 24 h. These cultures were used for the
subsequent experiments.
The viability of the cultures was assessed before use by serially
diluting in Maximum Recovery Diluent (MRD, Oxoid) and plating
onto nutrient agar. Cultures were transferred into 50 mL falcon tubes
(VWR U.K.) and cells were harvested by centrifugation at 9000 rpm
and 4 °C for 10 min in an Eppendorf 5804 Centrifuge. The
supernatant was then discarded and the pellet was resuspended in 1.5
mL ice chilled phosphate-buﬀered saline (PBS). A total of 20 μL of
this solution was then transferred in 200 μL of 0.5 wt % capA6R or 0.5
wt % A6R solution prepared in sterile water. Control solutions were
made by inoculating 200 μL of sterile water with 20 μL of the PBS
suspended culture. Solutions were then vortexed for 3 s, and samples
were taken at 0, 30, 60, and 1440 min. A total of 100 μL of the peptide
culture solution was then serially diluted in MRD, and subsequently,
10 μL of each dilution was plated onto plate count agar (PCA) and
incubated at 37 °C for 24 h before colony counting.
■ RESULTS
We ﬁrst examined the self-assembly of capA6R in water,
performing ﬂuorescence spectroscopy, CD, FTIR, XRD, SAXS,
and cryo-TEM experiments. Results are displayed in Figure 1.
Fluorescence assays using the dye Thioﬂavin T (ThT) were
performed to determine the critical aggregation concentration
of capA6R. Figure 1a plots the ﬂuorescence emission intensity
maximum for samples containing capA6R dissolved in 5 × 10
−3
wt % ThT (I), normalized by the ﬂuorescence emission
maximum for a sample containing only 5 × 10−3 wt % ThT
(Io). A discontinuity in the ﬂuorescence intensity ratio (I/Io) as
a function of capA6R concentration shows that the peptide self-
assembles into β-sheets, for concentrations higher than cac ∼
0.4 wt % capA6R (Figure 1a), lower than cac ∼ 1.4 wt % for
A6R previously determined by us.
15 This is consistent with the
increase in the hydrophobicity of the peptide as a result of
capping the termini.
Later in the manuscript, the peptide concentrations for the
study of capA6R binding to model anionic or zwitterionic
membranes (0.08, 0.25, or 0.5 wt % capA6R) were chosen in
increasing order; the highest capA6R concentration causing
macroscopic phase separation (sample precipitation) at ϕPOPG
= 0.2 + 0.5 wt % capA6R.
Figure 1. (a) cac results from ThT assays on capA6R. (b) CD, (c)
FTIR, (d) XRD, (e) SAXS, and (f) cryo-TEM images measured for
capA6R below and above the cac ∼ 0.4 wt % capA6R, determined in
(a).
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The CD spectra for 0.08−0.5 wt % capA6R (Figure 1b),
show a minimum at 190 nm, corresponding to a disordered
structure.10,11 In contrast, the CD spectrum for 1 wt % capA6R
shows a deep maximum at 190 nm along with a shallow
minimum at 223 nm, a signature of a β-sheet structure.10,11
The FTIR data for 0.08−0.5 wt % capA6R in Figure 1c show
a band centered at 1645 cm−1, corresponding to a disordered
structure,44 together with a peak at 1673 cm−1 due to bound
TFA counterions.45−48 At 1 wt % capA6R, the FTIR band at
1645 cm−1 becomes very weak compared to a sharp peak at
1621 cm−1 related to the β-sheet structure of the self-assembled
peptide.44,49 Notably, both CD and FTIR seem less sensitive
than the ThT ﬂuorescence to the formation of β-sheet
structures at concentrations higher than cac ∼ 0.4 wt % capA6R.
The XRD spectrum for 1 wt % capA6R in Figure 1d
resembles that previously reported by us for 17 wt % A6R. In
analogy to our previous XRD pattern indexation,15 we assign
reﬂections in Figure 1d correspond to the packing of the
polyalanine β-sheets (5.28 Å) and intrasheet spacings (4.36,
3.71, 2.94, and 2.65 Å).
Solutions containing 0.08 and 0.25 wt % capA6R provided a
very poor SAXS signal, due to their low concentration (e.g.,
Figure 1e). The statistics is improved for 0.5 wt % capA6R, but
a successful analytical ﬁtting of the SAXS data could only be
performed for 1 wt % capA6R (Figure 1e). Nevertheless, a
dependence of ∼q−1 in the SAXS curve at very low angles,
signals the formation of ﬁbers in the solution50 (Figure 1e).
The full lines in Figure 1e correspond to ﬁts of the SAXS data
for 1 wt % capA6R using a long cylindrical shell model, using
the software SASﬁt.51,52 The parameters of the model are the
core radius R (with polydispersity ΔR), the shell thickness Dr,
and the scattering length density of the core, shell, and solvent
ηcore, ηshell, and ηsolv. The parameters extracted from the ﬁtting
are listed in Table S1. The values, R ± ΔR = (18 ± 10) Å and
Dr = 4.5 Å, indicate that the cylinder core has a radius similar to
the length of the capA6 sequence = 22.4 Å (spacing per residue
in a parallel β-sheet is 3.2 Å53), while the external shell has a
thickness similar to the size of the arginine headgroup.
Figure 1f shows a cryo-TEM image of a sample containing 1
wt % capA6R. The image shows the formation of long ﬁbers,
∼(3.5 ± 0.7) nm in diameter. The thickness of the ﬁbers is
close to the diameter 2 × (Dr + R) = (4.5 ± 2.0) nm of the
ﬁbrils estimated from the SAXS parameters listed in Table S1.
Our results show that capping the C-terminus of the A6R
peptide lowers the cac concentration from 1.4 to 0.4 wt %
peptide and allows for peptide self-assembly into long ﬁbers at
1 wt % capA6R. We did not observe the formation of ultrathin
sheets or peptide nanotubes, previously reported for A6R
solutions.15 The reduced electrostatic interactions in capA6R
favor the self-assembly into ﬁbrils with a β-sheet structure, at
concentrations higher than the cac.
Having examined the self-assembly of capA6R in water, we
will study the interaction of capA6R with model anionic or
zwitterionic membranes represented by POPG/POPE or
POPC/DOPC vesicles, respectively. Results will be compared
with those obtained for A6R interacting with similar model
membranes. Table S2 lists the samples studied. Mostly all
samples were cloudy in appearance (but stable, with no
evidence of precipitation). The texture of sample ϕPOPG = 0.2 +
0.25 wt % capA6R was slightly grainy, while precipitation
eventually occurred for ϕPOPG = 0.2 + 0.5 wt % capA6R. The
latter sample presented phase separation as a white precipitate
and a transparent supernatant (Table S2). As mentioned above,
we prepared samples spanning capA6R concentrations such that
the higher peptide concentration used in this work, 0.5 wt %, is
determined as the peptide concentration causing macroscopic
precipitation for any of the mixed lipid/peptide samples (Table
S2); in this case, ϕPOPG = 0.2 + 0.5 wt % capA6R.
The interaction of capA6R with anionic and zwitterionic
vesicles was ﬁrst studied by SAXS. Figure 2a shows the SAXS
data measured for solutions containing ϕPOPG = 0.2 + 0, 0.08,
or 0.25 wt % capA6R. Figure S1 shows the SAXS and WAXS
data measured for ϕPOPG = 0.2 + 0.5 wt % capA6R. The gel
point of capA6R is at ∼8 wt % peptide. Data corresponding to a
gel containing ϕPOPG = 0.2 + 8.5 wt % capA6R is included in
Figure S1 only as a reference.
Figure 2b shows the SAXS curves measured for solutions
containing ϕDOPC = 0.2 + 0, 0.08, 0.25, or 0.5 wt % capA6R.
The spacings 2π/qo (qo = peak position) measured from the
SAXS curves in Figures 2 and S1a are listed in Table S3,
together with the associated layer spacings. In the following
notation, layer spacing d1 is associated with structures
containing only POPE, while layer spacing d is associated
with structures involving the mixture of lipids. All the ratios
between spacings listed in Table S3 indicate lamellar order for
the samples studied in this work.
SAXS data for ϕPOPG = 0.2 (Figure 2a) shows a broad peak
centered at ∼0.1 Å−1 arising from a single bilayer form factor.
This sample it is at the Lβ (ordered gel phase)/Lα (disordered
liquid crystal structure) phase coexistence, according to the
phase diagram of POPG/POPE vesicles reported in the
literature.32
The SAXS data for ϕPOPG = 0.2 + 0.08 wt % capA6R is
characterized by two broad peaks at 82.9 and 42.2 Å. This order
increases for the sample with ϕPOPG = 0.2 + 0.25 wt % capA6R,
for which SAXS is characterized by three peaks corresponding
to spacings 82.9, 61.6, and 42.2 Å (Figure 2a).
Peaks corresponding to spacings at (82.9 ± 1.0) Å and (42.2
± 1.0) Å are broad peaks in a positional ratio of 1:2 and
correspond to a layer spacing d = 82.9 Å (Figure 2a, Table S3).
The notably sharper Bragg peak with a spacing (61.6 ± 1.0) Å
is the same as that previously measured by us for a sample
containing 0.5 wt % POPE at 20 °C,54 and therefore, we assign
Figure 2. SAXS data measured for vesicles with (a) ϕPOPG = 0.2 and
(b) ϕDOPC = 0.2, mixed with 0.08, 0.25, or 0.5 wt % capA6R. SAXS
data has been multiplied by an arbitrary factor in order to enable the
visualization of the data.
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it to the presence of a separate population of POPE bilayers at
ϕPOPG = 0.2 + 0.25 wt % capA6R.
Diﬀerential scanning calorimetry (DSC) has been frequently
used to investigated demixing of mixed lipid membranes upon
loading a charged peptide. For example, DSC was used to
investigate the demixing of DPPG/DPPE membranes in the
presence of the antimicrobial peptide K0−W6−Hya1,55 or the
demixing of POPE/cardiolipin membranes upon binding of
antibacterial peptides derived from Human Lactoferricin.56 The
melting temperature Tm of POPG is −2 °C, very close to the
melting point of ice, and our DSC measurements on POPG/
POPE vesicles containing capA6R were unsuccessful because
the melting endotherm of the POPG was screened by the ice
melting endotherm. We therefore assign the presence of a
separate population of POPE bilayers based on the evidence
given by SAXS results (spacing 61.6 Å in Figure 2a).
In the case of the sample ϕPOPG = 0.2 + 0.5 wt % capA6R
(Figure S1a), the SAXS from the supernatant does not present
any particular feature and corresponds to monomers. The
SAXS data measured for the precipitate of ϕPOPG = 0.2 + 0.5 wt
% capA6R (Figure S1a) presents peaks corresponding to 83.9,
42.2, and 28.6 Å (layer spacing d = 83.9 Å) and spacings 61.4
and 31.1 Å (layer spacing d1 = 61.4 Å) are consistent with
lamellar order (Table S3, all peak spacings have an uncertainty
of ±1.0 Å). In particular, as discussed before, the cell parameter
d1 = 61.4 Å denotes the formation of a population rich in POPE
bilayers.
The SAXS data for ϕPOPG = 0.2 + 8.5 wt % capA6R (Figure
S1a) is dominated by the scattering from the peptide ﬁbrils
making the hydrogel, although the spacing = 63.4 Å denotes the
existence of POPE lamellae rich-domains. Spacings 82.9 or 83.9
Å, measured for samples below the capA6R gel point (Table
S3), are not present for ϕPOPG = 0.2 + 8.5 wt % capA6R, where
the peptide is self-assembled in a compact network of ﬁbers.
We can conclude that spacings 82.9 or 83.9 Å spacings originate
from capA6R monomers binding to the POPE/POPG
membrane.
The WAXS data in Figure S1b displays two reﬂections at 4.4
and 4.2 Å for the precipitate ϕPOPG = 0.2 + 0.08 wt % capA6R
and one reﬂection at 4.23 Å for the gel ϕPOPG = 0.2 + 8.5 wt %
capA6R (reﬂection at 4.4 Å appears as a shoulder in the WAXS
curve). Spacings at 4.2 and 4.23 Å arise from the POPE, and are
very close to the average separation of 4.3 Å for the POPE lipid
chains in the all-trans conﬁguration of the Lβ phase.32,57 The
spacing at 4.4 Å is characteristic of the capA6R β-sheet structure
(Figure 1d).
Overall, Figures 2a and S1 show that progressive addition of
capA6R to POPG/POPE vesicles leads to the stacking of the
lipid bilayers into multilamellar vesicles. However, concen-
trations of peptide equal or higher than 0.25 wt % capA6R lead
to POPE phase separation.
Figure 2b shows that POPC/DOPC vesicles, present a
multilamellar structure at 20 °C with a cell parameter d = 64.4
Å.54 The SAXS signal of POPC/DOPC MLVs becomes
increasingly screened by the form factor of a peptide ﬁber upon
progressive addition of capA6R to the system (Figure 2b).
The nanostructure of the solutions in Figure 2 was further
analyzed through the ﬁtting of the SAXS data to models for the
form factor and structure factor of a lamellar structure. Details
of the model58 are provided in the Supporting Information. We
only ﬁtted the samples without rich POPE lamellar domains.
Fits to the SAXS data in Figure 2 are displayed along with the
experimental data in Figure S2. Parameters extracted from the
ﬁtting are listed in Table S4. Figure S3 shows the electron
density distribution across the bilayers, calculated from the
parameters listed in Table S4.
Results obtained from the ﬁtting of the SAXS data describe
the bilayer correlation induced upon addition of capA6R to
ϕPOPG = 0.2 vesicles. The distance between lipid head groups in
the ϕPOPG = 0.2 bilayer, lH = 47 Å, increases to lH = 51.8 Å for
ϕPOPG = 0.2 + 0.08 wt % capA6R (Table S4 and Figure S3).
This increase is due to the insertion of capA6R in the POPG/
POPE bilayer. The addition of 0.08 wt % peptide to ϕPOPG =
0.2 also increases the length of correlation from 0 to 2 bilayers
(N = 2 in Table S4).
Similarly, the ﬁtting of the SAXS data describes the
decorrelation of bilayers induced upon addition of capA6R to
ϕDOPC = 0.2 vesicles. The distance between lipid head groups in
the ϕDOPC = 0.2 bilayer is lH = 47.1 Å and remains nearly
constant for ϕDOPC = 0.2 mixed with 0.08, 0.025, or 0.5 wt %
capA6R. However, the length of correlation of the bilayers
decreases from N = 8 to N = 2.3 by adding 0.5 wt % capA6R to
ϕPOPG = 0.2 (Table S4).
As mentioned above, the extended length of the capA6R
molecule as ∼22.4 Å. For the mixtures with ϕPOPG = 0.2, an
increase in 4 Å for 2zH upon adding peptide indicates that the
peptide is nearly fully inserted inside the POPG/POPE
membrane. This conﬁguration is probably driven by electro-
static interactions between the arginine residue in capA6R and
the phosphate group in POPG, as well as the formation of
bidentate hydrogen bonds between the arginine guanidinium
group and the phosphate group.5,6 Attractive interactions
between the peptide and the lipid bilayer are not present for
increasing concentrations of capA6R mixed with ϕDOPC = 0.2,
where N decreases with peptide increasing concentration. It is
likely that in the latter case the peptide decorates the surface of
the zwitterionic bilayers inducing an electrostatic repulsion that
leads to the reduction in N recorded in Table S4.
For zwitterionic membranes, the decorrelation of lipid
bilayers is caused by undulations at the surface of the lipid
bilayers. Indeed, the Caille ́ parameter η, which is a measure of
the bilayer ﬂuctuations,59 increases from 0.5 to 3.1 for a
constant ϕDOPC = 0.2 with peptide concentration increasing
from 0 to 0.5 wt % capA6R (Table S4).
Figure 3 shows the CD data measured for pure 0.08 or 0.25
wt % capA6R and samples containing 0.08 or 0.025 wt %
capA6R with ϕPOPG = 0.2 or ϕDOPC = 0.2. The CD spectra for
0.08 or 0.25 wt % capA6R are the same as that displayed in
Figure 1b, consistent with a disordered structure, and are
displayed here as a reference.44 A disordered secondary
structure is also observed for ϕDOPC = 0.2 + 0.08 or 0.25 wt
% capA6R. However, the peptide secondary structure becomes
β-sheet (the spectrum contains broad minimum just below 220
nm)44 for samples containing ϕPOPG = 0.2 + 0.08 or 0.25 wt %
capA6R. This indicates that interaction between capA6R and
POPE/POPG membrane orders the peptide into a β-sheet
structure. The intermolecular hydrogen bonding needed for β-
sheet formation is favored by the insertion of capA6R inside the
POPE/POPG membrane according to Scheme S2, where
electrostatic interactions and bidentate hydrogen bond
formation drive association between the arginine residue and
the lipid headgroup.
Stabilization and changes in a peptide structure, driven by the
interaction of a peptide with a negatively charged lipid
membrane, have already been reported in the literature. For
example, the structure adopted by the peptide α-melanocyte
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(α-MSH) when it is inserted in a negatively charged binary
membrane (DMPC/DMPG or DMPC/DMPA)60 is likely to
inﬂuence the peptide biological activity, but it is diﬀerent from
the structure of α-MSH in solution.
The nanostructures of the lipid/peptide mixtures were also
studied by cryo-TEM. Inspecting all cryo-TEM images we were
able to classify vesicles according to three types shown in
Figure 4, along with representative examples: (i) simple thin
wall vesicles, (ii) thin wall vesicles with internal structure, i.e.
internal compartmentalization, (iii) multilamellar vesicles with
uncorrelated layers and typically (but not necessarily) internal
compartmentalization, (iv) type (iii) vesicles joined by an
elongated layered structure. Classiﬁcation (i−iv) is modiﬁed
from that introduced in ref 32 for POPG/POPE vesicles in the
absence of peptide and extends to POPC/DOPC vesicles
studied in this work. Table S3 summarizes vesicle morphologies
identiﬁed by cryo-TEM, along with the summary of the SAXS
data features discussed above. Figures 5−7 and Figure S4 show
representative cryo-TEM images.
A repeat distance dcryo = (95 ± 12) Å can be measured for
vesicles at ϕPOPG = 0.2 + 0.25 wt % capA6R (Table S3 and
Figure 5f), corresponding to the cell parameter d = 82.9 Å in
the SAXS curve (Figure 2a).
Layer spacings dcryo = (62 ± 0.1) and dcryo = (67.9 ± 4.2) Å,
measured in the cryo-TEM images for ϕDOPC = 0.2 + 0 and
0.08 wt % capA6R, respectively (Table S3, Figure 6, and Figure
S4), correspond to the lamellar cell parameter in Figure 3b (d =
64.4 Å, Table S3). These repeat distances can be measured at
the walls of the vesicles (Figure 6) or in the elongated lamellar
structures joining vesicles (inset Figure 6). These remarkable
tubular structures resemble previously observed lipid tubule
structures, which are observed in response to gradients in
environmental parameters such as temperature and pH,61,62 the
formation of which is ascribed to a surface tension arising from
an asymmetry in the surface area of inner and outer membrane
surfaces (“leaﬂets”).63,64 The same mechanism has been
proposed to explain the structure of other nonspherical cell
structures such as those of red blood cells. We propose that
here, the tubule structure is formed due to the decorrelation
between the vesicle inner and outer lamellae induced by the
interaction of capA6R with the zwitterionic lipids in the outer
vesicle surface.
A spacing between membranes of dcryo = (214 ± 26) Å,
measured for ϕDOPC = 0.2 + 0.25 wt % capA6R (Figure 7a),
does not correspond to a regular repeat distance, and can be
associated with the progressive decorrelation of the bilayers
observed in the SAXS data (Figure 2b). The cryo-TEM image
in Figure 7b is consistent with the SAXS curve displayed in
Figure 2b for ϕDOPC = 0.2 + 0.5 wt % capA6R, which contains a
major contribution from a peptide ﬁbril form factor.
The interaction of A6R with POPE/POPG and POPC/
DOPC vesicles was studied by SAXS to understand the
inﬂuence of the capped termini on the interaction of capA6R
with the vesicles. SAXS intensity proﬁles are displayed in Figure
S5a,b; SAXS spacings are listed in Table S3, together with their
corresponding d-spacing ratio and cell parameter. Control
SAXS data for 0.5 wt % A6R, displayed in Figure S6, does not
show any particular feature that could inﬂuence the SAXS data
Figure 3. CD data measured for samples containing pure (a) 0.08 wt
% or (b) 0.25 wt % capA6R or mixtures of the peptide with vesicles
containing ϕPOPG = 0.2 or ϕDOPC = 0.2.
Figure 4. Classiﬁcation of vesicle types. (i) Thin wall vesicles with no internal structure, (ii) compartmentalized thin wall vesicles, (iii) multilayer
vesicles with uncorrelated layers and compartmentalization, (iv) type (iii) vesicles joined together by layered tubule structure. Typical cryo-TEM
images for the three types (a) ϕPOPG = 0.2 + 0.25 wt % A6R (type (i)), (b) ϕDOPC = 0.2 + 0.25 wt % A6R (type (ii)), (c) ϕDOPC = 0.2 + 0.25 wt %
capA6R (type (iii)), and (d) ϕDOPC = 0.2 + 0.08 wt % capA6R (type (iv)).
Biomacromolecules Article
DOI: 10.1021/acs.biomac.8b00391
Biomacromolecules XXXX, XXX, XXX−XXX
G
Figure 5. Cryo-TEM images for ϕPOPG = 0.2 mixed with (a) 0, (b−d) 0.08, or (e−g) 0.25 wt % capA6R.
Figure 6. Cryo-TEM image for ϕDOPC = 0.2 mixed with 0.08 wt %
capA6R. The inset shows a detail of the elongated layered structure
joining some of the vesicles. Figure 7. Cryo-TEM image for ϕDOPC = 0.2 mixed with (a) 0.25 or
(b) 0.5 wt % capA6R.
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in Figure S5 (SAXS for 0.08 and 0.25 wt % A6R has been
omitted from Figure S6 due to its weak scattering signal).
Figure S5a shows that progressive addition of A6R to POPG/
POPE vesicles leads to a transition of a small fraction of vesicles
from a unilamellar to a multilamellar structure, denoted by the
spacing at 65.9 Å.32 The multilamellar order with bilayer
spacing 82.9 Å, measured for samples containing capA6R in
Figure 3a, is not present in Figure S5a. In contrast to capA6R,
A6R is not incorporated into the POPG/POPE bilayer. We
suggest that the insertion of capA6R in the POPG/POPE
membrane is favored by the increase in the hydrophobicity of
the peptide as a result of capping the termini.
The SAXS intensity proﬁles for ϕDOPC = 0.2 + 0, 0.08, 0.25,
or 0.5 wt % A6R (Figure S5b) are similar to those discussed
above in relation to samples containing mixtures of capA6R and
POPC/DOPC vesicles (Figure 2b), although there is no
development of a peptide ﬁbril form factor contribution at 0.5
wt % A6R. Instead, there is a loss of the layer structure factor
peaks as the A6R concentration increased and the development
of form factor characteristic of unassociated lipid bilayers for
0.08−0.5 wt % A6R. This result is consistent with the outcome
from our previous study of A6R/DPPC MLV interaction, where
we concluded that addition of A6R to the zwitterionic DPPC
MLVs eliminates the MLV Bragg peaks from the SAXS
proﬁle.25
Figure S7 shows the CD data measured for pure 0.08 or 0.25
wt % A6R and samples containing 0.08 or 0.025 wt % A6R with
ϕPOPG = 0.2 or ϕDOPC = 0.2. The secondary structure of A6R in
Figure S7a,b is consistent with a disordered structure,44
independently of being dissolved in water or mixed with
anionic or zwitterionic vesicles.
Overall, SAXS and CD results for mixed A6R/lipid systems
conﬁrm that capping A6R allows insertion of the peptide, self-
assembled in a β-sheet structure, inside POPG/POPE
membranes, but this is not observed for A6R.
Cryo-TEM was used to conﬁrm the structure of the mixtures
of lipids with A6R. Figure S8 shows the cryo-TEM images
measured for ϕPOPG = 0.2 + 0.25 wt % A6R or ϕDOPC = 0.2 +
0.25 wt % A6R. In good agreement with SAXS data, cryo-TEM
for ϕDOPC = 0.2 + 0.5 wt % A6R (Figure S9) shows the
formation of vesicles with thin walls.
To examine the cytocompatibility of capA6R and A6R, the
viability of the peptide was tested using 161Br skin ﬁbroblast
cells via MTT assays (Figure 8). Peptide capA6R was tolerated
by the cells up to a concentration of 0.01 wt % (∼75%
viability). But a lower cell viability <70% was observed from
0.05 to 0.5 wt % capA6R. A6R was tolerated by the cells up to a
concentration of 0.1 wt % (∼80.7% viability), but viability is
relatively low for 0.25 and 0.5 wt % A6R. Results in Figure 8
show that modifying the termini of A6R in capA6R increased
the toxicity of the peptide on 161Br skin ﬁbroblast cells,
presumably due to the increased interaction of the arginine
residue with the zwitterionic PC lipids in the cell membranes,
consistent with the SAXS and cryo-TEM data presented here.
The antimicrobial activity of the capA6R peptide was studied
using one model Gram negative microorganism, E. coli,65 and
two Gram positive microorganisms, S. aureus and L.
monocytogenes.41,66 Microorganisms were treated with 0.5 wt
% capA6R or 0.5 wt % A6R.
Figure 9 displays the antimicrobial assays results showing the
antimicrobial activity of the capA6R peptide against S. aureus, L.
monocytogenes, and E. coli. An eﬀect of the peptide treatment in
the range of 1.8 log reduction of the CFU/ml was found against
E. coli which, however, was not statistically signiﬁcant. But a
statistically signiﬁcant antimicrobial eﬀect was found with the L.
monocytogenes and S. aureus. In particular, a major eﬀect of 4.7
log reduction in CFU/ml was found with L. monocytogenes,
while a less pronounced eﬀect in the range of 1.2 log reduction
of the CFU/ml was seen with S. aureus. Both of these bacteria
are Gram positive, that is, their membrane contains
peptidoglycans which bear anionic residues (Glu).67−69 In
addition, the membranes of Gram positive bacteria contain
lipoteichoic acid, which bears negatively charged phosphate
groups.67−69 We propose that the cationic arginine residue in
capA6R interacts with these two types of anionic groups,
causing lipid membrane disruption ultimately killing these
microbes.
Overall, Figure 9 shows a dramatic eﬀect of capA6R on the
numbers of bacteria within the ﬁrst 1 h. Subsequently, the
numbers of E. coli and S. aureus somehow remained stable
Figure 8. Cell viability proﬁles for capA6R and A6R. Error bars: SEM
(n = 3). *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 9. Survival of (a) S. aureus, (b) E. coli, and (c) L. monocytogenes
after exposure to the presence or absence of 0.5 wt % capA6R. (d)
Combined plot of data in (a)−(c). Estimations of the cell numbers
(CFU: colony-forming units) at each time point were performed in
triplicate (3 biological replicates), while each dilution was plated in
duplicate (2 technical replicates). Markers represent an average of the
measurements performed in triplicate, and error bars represent the
standard deviation. The dotted line represents the detection limit of
the method. Asterisks denote statistically signiﬁcant diﬀerent results
comparing the treated and untreated strains at a speciﬁc time point as
assessed by t-test (P < 0.05).
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within the next 22 h. However, in the case of L. monocytogenes a
more pronounced eﬀect was seen within the ﬁrst 1 h, while the
reduction continued for the following 22 h.
Figure S10 displays the antimicrobial assays results showing
the antimicrobial activity of the A6R peptide against S. aureus, L.
monocytogenes, and E. coli. Figure S10 supports our previous
study on the uncapped peptide A6R, which included results of
preliminary antimicrobial activity assays against S. aureus and E.
coli treated with 0.5 wt % A6R.
25 We observed that the
treatment with A6R was more eﬀective against Gram-positive S.
aureus than E. coli; however, the measurements only extended
up to 1 h. The data presented here (Figure S10) extend up to
24 h. Comparing capA6R and A6R (Figure S11), it is clear that
A6R has greater antimicrobial activity against all three studied
microbes, including Gram positive and Gram negative bacteria.
This shows the strong eﬀect of the charge in the region of the
arginine residue at the C terminus.
■ SUMMARY AND CONCLUSIONS
We have used a model peptide system with model lipid
membranes to study the interaction of arginine-based
antimicrobial peptides with cell and bacterial membranes.
The results presented in this work help to understand how to
improve the development of selective noncytotoxic antimicro-
bial peptides as potential therapeutic agents.
Our results show that peptide self-assembly and peptide
interaction with lipid membranes can be tuned by subtle
adjustment of peptide charge by end-capping. It is remarkable
the degree to which vesicle membrane restructuring can be
controlled by peptides containing single arginine residues and
how this depends on the electrostatic interactions which are
enhanced when the termini are capped (as is the hydro-
phobicity of the peptide).
Scheme 2 summarizes the changes in lipid organization
induced by capA6R (in monomeric form at low concentration),
Scheme 2. Proposed Interaction of capA6R with Lipid Bilayers
a
a(a) Mixed POPG/POPE bilayers before addition of capA6R. (b) Added capA6R interacts selectively with POPG, peptide β-sheet structures (e.g. red
dashed sheet) being observed by CD, SAXS shows that POPE forms a distinct bilayer structure (in proposed rafts). (c) Mixed DOPC/POPC
bilayer. (d) Added capA6R is absorbed at the surface of the mixed bilayer causing membrane de-correlation. At higher concentration, excess
unadsorbed capA6R forms peptide ﬁbrils (e.g. Figure 7b).
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as deduced from our SAXS and CD measurements. The POPG
and POPE lipids are mixed in the lipid bilayers. SAXS (Figure
2a) shows the features of unstacked lipid bilayers. Added
capA6R interacts selectively with anionic POPG forming
peptide β-sheets (as shown by CD, Figure 3) and consistent
with SAXS which shows peaks with a spacing signiﬁcantly
expanded from that of the lipid bilayer, which is ascribed to the
incorporation of the peptide into the bilayer. At the same time,
the SAXS data indicates the presence of a separate population
of POPE bilayers (sharper Bragg peak at 61.6 Å in Figure 2a).
This is presumably due to phase separation of POPE rafts as
indicated in Scheme 2b. The mixed DOPC/POPC bilayers
have a well-correlated multilamellar structure according to
SAXS (Figure 2b). Addition of capA6R leads to decorrelation of
the layers (and at certain compositions of added capA6R, the
formation of tubule structures). We propose that this is due to
adsorption of capA6R at the outer surface. Electrostatic
repulsion between the arginine residues on opposing layers
will lead to the observed (via SAXS) decorrelation of the bilayer
ordering. Excess added capA6R (0.5 wt% capA6R) self-
assembles into peptide ﬁbrils as shown by cryo-TEM
(Figure7b). Peptide A6R behaves similarly to capA6R in the
presence of the DOPC/POPC lipids (see, for example, the
SAXS proﬁles in Figure S5b compared to Figure 2b), with the
diﬀerence that there is no contribution from peptide form
factor at higher A6R concentration in contrast to capA6R (for
which cryo-TEM also conﬁrms ﬁbril formation). On the other
hand, A6R does not show signiﬁcant interactions with the
POPG/POPE membranes as shown by the SAXS data in
Figure S5a. Only a small fraction of the bilayers become
correlated with 0.5 wt % added A6R. We propose that the
adsorption of capA6R and A6R onto the DOPC/POPC bilayers
resembles the initial stage of the “carpet mechanism” of
adsorption of antimicrobial peptides onto membranes.1,4,19,20
Peptide A6R shows greater antimicrobial activity than capA6R
against all three microbes studied including one Gram negative
and two Gram positive bacteria. This occurs despite the weaker
interaction of A6R with the model anionic membranes which
our SAXS, cryo-TEM, and CD studies reveal. This shows that
considering the interaction with model lipid membranes alone
is insuﬃcient to account for the antimicrobial activity and that
interactions with the other components of the outer membrane
(peptidoglycan in the case of Gram positive bacteria or
lipopolysaccharide in the case of Gram negative bacteria) must
be of predominant importance in the interaction with cationic
peptides. Nevertheless, our study provides good foundation for
future studies to understand less trivial processes involving, for
example, membrane permeation. Our work shows that even
subtle changes in the charge around a single arginine residue
can profoundly inﬂuence binding to model lipid membranes,
but also that additional interactions with polysaccharides/
glycans must account for the antimicrobial activities.
In future work, the mechanisms of the interactions of capA6R
and A6R with the model lipid membranes will be further
examined at the nanoscale via molecular dynamics simulations.
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